Celldonate Inc. - FORM 10-K - XML - IDEA: XBRL DOCUMENT - June 27, 2012



Attached files
FileFilename
XML - IDEA: XBRL DOCUMENT - Celldonate Inc.R5.htm
10-K - ANNUAL REPORT - Celldonate Inc.form10k.htm
XML - IDEA: XBRL DOCUMENT - Celldonate Inc.R10.htm
XML - IDEA: XBRL DOCUMENT - Celldonate Inc.R14.htm
XML - IDEA: XBRL DOCUMENT - Celldonate Inc.R13.htm
XML - IDEA: XBRL DOCUMENT - Celldonate Inc.R11.htm
XML - IDEA: XBRL DOCUMENT - Celldonate Inc.R12.htm
XML - IDEA: XBRL DOCUMENT - Celldonate Inc.R1.htm
XML - IDEA: XBRL DOCUMENT - Celldonate Inc.R3.htm
XML - IDEA: XBRL DOCUMENT - Celldonate Inc.R7.htm
XML - IDEA: XBRL DOCUMENT - Celldonate Inc.R6.htm
XML - IDEA: XBRL DOCUMENT - Celldonate Inc.R2.htm
XML - IDEA: XBRL DOCUMENT - Celldonate Inc.R8.htm
EXCEL - IDEA: XBRL DOCUMENT - Celldonate Inc.Financial_Report.xls
XML - IDEA: XBRL DOCUMENT - Celldonate Inc.R9.htm
EX-32.1 - Celldonate Inc.ex32-1.htm
EX-31.1 - Celldonate Inc.ex31-1.htm
v2.4.0.6
Statements of Operations (Unaudited) (USD $)
12 Months Ended 68 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Mar. 31, 2012
Expenses      
Accounting and legal $ 37,338 $ 39,882 $ 196,046
Licenses and fees 25,077 19,441 64,024
Bank charges 599 599 2,089
Office 245    5,702
Consulting and development fees       63,728
Amortization       528
Net loss and comprehensive loss for period $ (63,259) $ (59,922) $ (332,117)
Basic and diluted loss per share $ 0.00 $ 0.00  
Weighted average number of common shares outstanding 22,910,000 22,910,000  

User Contributions:

Comment about this document or add new information about this topic:

CAPTCHA



This web site and associated pages are not associated with, endorsed by, or sponsored by Celldonate Inc. and has no official or unofficial affiliation with Celldonate Inc.


Based on public records. Inadvertent errors are possible.
Faqs.org does not guarantee the accuracy or timeliness of any information on this site.  Use at your own risk. This website is not associated with the SEC

Some parts © 2013 Advameg, Inc.